Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Message: PUBPAT
Historically, the USPTO has responded to PUBPAT's requests for patent review about 60 days after their submission. PUBPAT submitted the request to review '336 on Feb 1, so we should hear from the USPTO around April 1 if it follows the same trend.
Loading...
Loading...
Mar 16, 2007 09:07AM
Mar 16, 2007 09:10AM
Mar 16, 2007 09:15AM
Mar 18, 2007 08:56PM
Mar 19, 2007 06:36PM
New Message
Please
login
to post a reply